Skip to content

Drug interactions

Insulin degludec + Pentamidine

Severity: Major

Insulin degludec and Pentamidine: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pentamidine can damage pancreatic beta cells, causing early hypoglycemia from insulin release and later hyperglycemia or diabetes. Glucose control in patients on insulin degludec may be unpredictable.

What this interaction means in plain words

Insulin degludec and Pentamidine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Insulin degludec belongs to Endocrine; Pentamidine belongs to Anti Parasitic.

Evidence level: Moderate

Why it happens

Pentamidine causes pancreatic beta-cell toxicity, with initial insulin release followed by insulin deficiency.

What to do

Monitor blood glucose frequently during and after pentamidine treatment. Adjust the insulin degludec dose in both directions as readings change.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Insulin degludec and Pentamidine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Insulin degludec with Pentamidine?

MediHelp rates the interaction as major. Insulin degludec and Pentamidine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pentamidine can damage pancreatic beta cells, causing early hypoglycemia from insulin release and later hyperglycemia or diabetes. Glucose control in patients on insulin degludec may be unpredictable.

How serious is the interaction between Insulin degludec and Pentamidine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose frequently during and after pentamidine treatment. Adjust the insulin degludec dose in both directions as readings change.

What other medicines interact with Insulin degludec?

MediHelp also lists interactions of Insulin degludec with, for example, Alogliptin-pioglitazone, Ethanol, Glimepiride-pioglitazone. The full list is on the Insulin degludec page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in